Sponsor or institution
Clinical trials and research at Mabsoft Therapeutics (Shanghai) Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Mabsoft Therapeutics (Shanghai) Co., Ltd. that are recruiting, at sites in 2 countries (most in Australia (1), China (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
MST-931 in healthy adults
This early-phase study tests a single subcutaneous dose of MST-931 to see if it is safe and how it behaves in the body in healthy adults.
-
MST-168 first-in-human test in adults with advanced solid tumors
This early-phase study tests MST-168 in adults with target-driven advanced solid tumors to see if it is safe and tolerable and to gather initial signals of activity.
Quick answers
How many clinical trials run by Mabsoft Therapeutics (Shanghai) Co., Ltd. are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.